Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gallstone disease: current therapeutic practice.

Chad I Williams1, Eldon A Shaffer

  • 1Eldon A. Shaffer, MD, FRCP Division of Gastroenterology, University of Calgary, Translational Research and Wellness Building, Room 6D29, 3280 Hospital Drive NW, Calgary, Alberta T2N4N1, Canada. shaffer@ucalgary.ca.

Current Treatment Options in Gastroenterology
|March 7, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea.

Journal of the Canadian Association of Gastroenterology·2020
Same author

Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2019
Same author

Gallbladder cancer: epidemiology and outcome.

Clinical epidemiology·2014
Same author

Solitary lesions with fibrosis and increased IgG4+ plasma cells: part of the expanding spectrum of IgG4-related disease or a nonspecific inflammatory response?

International journal of surgical pathology·2013
Same author

Waiting for a consultation: Sorry, but the doctor cannot see you.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2012
Same author

Epidemiology of gallbladder disease: cholelithiasis and cancer.

Gut and liver·2012
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Gallstone treatment varies, with surgery for symptomatic cases and specific preventive measures for high-risk individuals. Ursodeoxycholic acid may prevent gallstones during rapid weight loss.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Surgical Gastroenterology

Background:

  • Gallstones affect a significant portion of the population.
  • Asymptomatic gallstones often require no intervention.
  • Symptomatic gallstone disease necessitates effective management strategies.

Purpose of the Study:

  • To review current therapeutic and preventive strategies for gallstone disease.
  • To highlight the role of laparoscopic cholecystectomy in managing symptomatic gallstones.
  • To discuss the limited but specific applications of medical therapy and endoscopic procedures.

Main Methods:

  • Review of existing literature on gallstone management.
  • Analysis of treatment outcomes for symptomatic and asymptomatic gallstones.

Related Experiment Videos

  • Evaluation of preventive measures and their efficacy.

    • Main Results:

    • Laparoscopic cholecystectomy is the preferred treatment for symptomatic gallstones.
    • Selective laparoscopic cholecystectomy offers secondary prevention in specific high-risk scenarios.
    • Ursodeoxycholic acid has a role in preventing gallstone formation during rapid weight loss.
    • Endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy is crucial for managing complications like pancreatitis and cholangitis.

    Conclusions:

    • Gallstone management should be tailored to the presence or absence of symptoms.
    • Laparoscopic cholecystectomy remains the gold standard for symptomatic gallstone disease.
    • Preventive strategies and endoscopic interventions have specific indications in gallstone management.